February 09, 2007 01:05 ET | Source: Novonesis (Novozymes A/S) Novonesis (Novozymes A/S)
Notice of 2007 annual shareholder meeting March 8
Please read the announcement in PDF Attachment 2026_28_Share_buyback ...
COPENHAGEN, Denmark – November 5, 2026. Novonesis delivered strong Q3 sales leading to 9M financial results at 7% organic sales growth and adjusted EBITDA margin of 37.9%. In addition, our 2026...